2004
DOI: 10.1016/j.ygyno.2004.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Malignant mesenchymoma arising from a uterine leiomyoma in the menopause

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 13 publications
1
11
0
Order By: Relevance
“…Tumors that contain two or more lineages of specialized differentiation have sometimes been described as "malignant mesenchymomas" in the past [3,12,15,16]. Since the group of malignant mesenchymomas represents no homogeneous clinicopathological entity, and the majority of tumors considered to be mesenchymomas can be classified in other ways (especially dedifferentiated liposarcomas), this entity seems to be gradually disappearing.…”
Section: Discussionmentioning
confidence: 99%
“…Tumors that contain two or more lineages of specialized differentiation have sometimes been described as "malignant mesenchymomas" in the past [3,12,15,16]. Since the group of malignant mesenchymomas represents no homogeneous clinicopathological entity, and the majority of tumors considered to be mesenchymomas can be classified in other ways (especially dedifferentiated liposarcomas), this entity seems to be gradually disappearing.…”
Section: Discussionmentioning
confidence: 99%
“…Although primary uterine osteosarcomas are well described [12], heterologous osteoid elements are extraordinarily rare in the uterine leiomyosarcomas. Previously reported examples of this phenomenon include 2 cases of complex tumors, reported as mesenchymomas , with leiomyosarcomatous, osteosarcomatous, and liposarcomatous elements [13, 14], 1 case of a mixed osteosarcoma/leiomyosarcoma [15] and 1 case of a conventional uterine leiomyosarcoma that metastasized as a high-grade sarcoma with a multitude of heterologous malignant mesenchymal elements that included osteosarcomatous, chondrosarcomatous, and liposarcomatous areas [16]. In 3 of these 4 cases, myogenic areas were clearly demonstrable either morphologically or immunohistochemically in the heterologous areas [1315].…”
Section: Discussionmentioning
confidence: 99%
“…It is documented that uterine leiomyosarcomas are aggressive tumors with an overall poor prognosis (15% to 25% 5-yr survival rate) (13). Although there are a limited number of cases, the behavior of uterine lipoleiomyosarcoma can correlate with leiomyosarcomas and other uterine sarcomas with heterologous components (3,14), which have a poor prognosis with long-term follow-up. Although there has been limited experience on treatment modality, postoperative adjuvant therapy is mandatory.…”
Section: Uterine Lipoleiomyosarcomamentioning
confidence: 99%